Figure 3.
(A) Induction of TOP1–DNA covalent cleavage complexes by in vivo complex of enzyme assay in MCF-7 cells. Lane 1, untreated control; lanes 2 and 3, cells treated with TPT at 25 and 50 μM, respectively; lanes 4–6, cells treated with C12 at 25, 50, and 100 μM, respectively. (B) Hypothetical binding mode of C12 in the ternary TOP1–DNA–drug cleavage complex (PDB: 1K4T). (C) Induction of TDP1-DNA covalent complex by ICE assay in MCF-7 and MCF-7/TDP1 cells. Lane 1, untreated control; lanes 2–4, cells treated with TPT (10 μM) and C12 at 10 and 100 μM, respectively; lanes 5 and 6, cells cotreated with TPT (10 μM) and C12 (10 and 100 μM).